Cognyte Software (NASDAQ:CGNT – Get Free Report) announced its earnings results on Tuesday. The medical device company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.12, Briefing.com reports. The company had revenue of $77.10 million for the quarter, compared to analyst estimates of $73.87 million. Cognyte Software […]
Research analysts at StockNews.com started coverage on shares of Cognyte Software (NASDAQ:CGNT – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the medical device company’s stock. Separately, Evercore ISI raised their target price on Cognyte Software from $3.00 to $5.00 in a report on Friday, June 16th. […]
Cognyte Software (NASDAQ:CGNT – Get Free Report) and Everbridge (NASDAQ:EVBG – Get Free Report) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations. Analyst Recommendations This is a summary […]
Cognyte Software (NASDAQ:CGNT – Get Free Report) and Clear Secure (NYSE:YOU – Get Free Report) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Profitability This table compares Cognyte Software […]
American Capital Management Inc. increased its stake in shares of Cognyte Software Ltd. (NASDAQ:CGNT – Free Report) by 21.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,915,875 shares of the medical device company’s stock after purchasing an additional 866,532 […]